Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 18, 2004; DOI: 10.1124/jpet.104.077990
0022-3565/05/3123-1266-1271$20.00
JPET 312:1266-1271, 2005
CARDIOVASCULAR
Raloxifene Relaxes Rat Pulmonary Arteries and Veins: Roles of Gender, Endothelium, and Antagonism of Ca2+ Influx
Yau-Chi Chan,
Fung-Ping Leung,
Xiaoqiang Yao,
Chi-Wai Lau,
Paul M. Vanhoutte, and
Yu Huang
Department of Physiology, Chinese University of Hong Kong, Hong Kong, China (Y.-C.C., F.-P.L., X.Y., C.-W.L., Y.H.); and Department of Pharmacology, University of Hong Kong, Hong Kong, China (P.M.V.)
Effects of raloxifene have been documented in the systemic circulation. However, its impact on the pulmonary circulation is unclear. The present study investigated the role of gender, endothelial modulation, and Ca2+ channel in relaxations evoked by raloxifene in rat pulmonary arteries and veins. Vascular responses were studied on isolated pulmonary blood vessels mounted in a myograph and constricted by U46619 (9,11-dideoxy-11
,9
-epoxymethanoprostaglandin F2
). Constrictions to CaCl2 were studied in Ca2+-free, 60 mM K+ solution. Changes in the intracellular calcium ion concentration ([Ca2+]i) in vascular smooth muscle were measured using a calcium fluorescence imaging method. Raloxifene was more effective in relaxing U46619-constricted pulmonary arteries from male than female rats. Raloxifene-induced relaxation was unaffected by ICI 182,780 [7
-[9-[(4,4,5,5,5,-pentafluoropentyl)-sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17
-diol], inhibition of the nitric oxide (NO) pathway, or removal of the endothelium. In arteries without endothelium, raloxifene attenuated CaCl2-induced constriction and CaCl2-stimulated increase in [Ca2+]i with similar potencies. Raloxifene caused endothelium-independent relaxations in pulmonary veins, albeit to a lesser degree than in pulmonary arteries. The venous responses showed a gender difference because raloxifene was more potent in male veins. In summary, raloxifene relaxed rat pulmonary arteries, and this effect did not involve the endothelium/NO or ICI 182,780-sensitive estrogen receptors. Raloxifene, like nifedipine, reduced constriction and [Ca2+]i increase in response to CaCl2 in high K+ solution. Raloxifene also relaxed high K+-constricted pulmonary veins. Our data indicate that raloxifene acutely relaxes rat pulmonary blood vessels primarily via inhibition of Ca2+ influx through voltage-sensitive Ca2+ channels. Finally, raloxifene induced more relaxation in blood vessels isolated from male than female rats.
Received September 16, 2004;
accepted November 12, 2004.
Address correspondence to: Dr. Yu Huang, Department of Physiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, NT, Hong Kong. E-mail: yu-huang{at}cuhk.edu.hk
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Bolanz, M. A. Hediger, and C. P. Landowski
The role of TRPV6 in breast carcinogenesis
Mol. Cancer Ther.,
February 1, 2008;
7(2):
271 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pinna, C. Bolego, P. Sanvito, V. Pelosi, R. Baetta, A. Corsini, R. M. Gaion, and A. Cignarella
Raloxifene Elicits Combined Rapid Vasorelaxation and Long-Term Anti-Inflammatory Actions in Rat Aorta
J. Pharmacol. Exp. Ther.,
December 1, 2006;
319(3):
1444 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. P. Leung, X. Yao, C.-W. Lau, W.-H. Ko, L. Lu, and Y. Huang
Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2+ influx
Am J Physiol Renal Physiol,
July 1, 2005;
289(1):
F137 - F144.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.